Brexit Good For UK Firms And Emerging Markets?
This article was originally published in PharmAsia News
Despite creating shockwaves around the globe, the UK’s ‘Brexit’ vote to leave the EU is expected by analysts to positively impact European pharma companies such as GSK, Sanofi and AstraZeneca. But the impact on product sales and emerging markets will be more of a mixed bag.
Register for our free email digests: